📰 Use Listing News
Page 11 - Use Listing News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Use Listing. Real-time updates on events, politics, business and more.
December 21, 2021
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...
December 20, 2021
Bharat Biotech has submitted an application for phase 3 trials to the Drugs Controller General of India for its intranasal vaccine.
December 20, 2021
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...
December 20, 2021
An opened vial of Covid-19 vaccine Covaxin can be stored at 2 to 8 degrees Celsius for up to 28 days and is not required to be discarded immediately in a day or at the end of immunisation session, Bharat Biotech said on Monday.Each vial of ...
December 20, 2021
Press release content from PR Newswire. The AP news staff was not involved in its creation.
December 20, 2021
Bharat Biotech has sought the Drug Controller General of India's approval to conduct phase-3 trials of its intranasal vaccine (BBV154) against Covid to be used as a booster dose, sources said on Monday.
December 20, 2021
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...
December 20, 2021
Hyderabad, December 20 Bharat Biotech has sought the Drug Controller General of India's approval to conduct phase-3 trials of its Covid-19 intranasal vaccine (BBV154) to use as booster dose, sources
December 20, 2021
- Nuvaxovid™ COVID-19 Vaccine (SARS-CoV-2 rS [Recombinant, adjuvanted]) listed for emergency use by the WHO - EUL for Nuvaxovid complements listing for Novavax vaccine manufactured and marketed by Serum Institute of India as Covovax™ - EUL by WHO is a prerequisite for exports to numerous countries participating in the COVAX Facility GAITHERSBURG, Md., Dec. 21, 2021 /PRNewswire/ --...
December 20, 2021
- Nuvaxovid COVID-19 Vaccine (SARS-CoV-2 rS [Recombinant, adjuvanted]) listed for emergency use by the WHO - EUL for Nuvaxovid complements listing for Novavax vaccine manufactured and marketed